Guizhou Bailing Group Pharmaceutical Co Ltd (002424) — Capital Reinvestment Ratio
Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥294.76 Million) in capital expenditures (CN¥3.59 Million). See 002424 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guizhou Bailing Group Pharmaceutical Co Ltd Capital Reinvestment Ratio (2009–2025)
This chart tracks Guizhou Bailing Group Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 15 annual periods. Check Guizhou Bailing Group Pharmaceutical Co (002424) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Guizhou Bailing Group Pharmaceutical Co Ltd (2009–2025)
Year-by-year Capital Reinvestment Ratio for Guizhou Bailing Group Pharmaceutical Co Ltd from 2009 to 2025. For live market cap and broader valuation context, see Guizhou Bailing Group Pharmaceutical Co market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | CN¥748.72 Million | CN¥125.24 Million | ▼ -96.4% |
| 2024 | 4.66x | CN¥9.02 Million | CN¥42.02 Million | ▲ +462.6% |
| 2023 | 0.83x | CN¥125.77 Million | CN¥104.12 Million | ▲ +507.3% |
| 2022 | 0.14x | CN¥502.15 Million | CN¥68.45 Million | ▼ -89.6% |
| 2021 | 1.31x | CN¥324.92 Million | CN¥425.73 Million | ▲ +237.3% |
| 2020 | 0.39x | CN¥231.78 Million | CN¥90.02 Million | ▲ +48.9% |
| 2019 | 0.26x | CN¥467.41 Million | CN¥121.91 Million | ▼ -85.6% |
| 2017 | 1.81x | CN¥79.88 Million | CN¥144.68 Million | ▲ +430.4% |
| 2016 | 0.34x | CN¥466.62 Million | CN¥159.34 Million | ▲ +16.6% |
| 2015 | 0.29x | CN¥413.23 Million | CN¥121.04 Million | ▲ +20.2% |
| 2014 | 0.24x | CN¥395.83 Million | CN¥96.49 Million | ▼ -61.1% |
| 2013 | 0.63x | CN¥141.76 Million | CN¥88.74 Million | ▼ -93.2% |
| 2012 | 9.23x | CN¥19.52 Million | CN¥180.16 Million | ▲ +865.3% |
| 2011 | 0.96x | CN¥201.90 Million | CN¥193.07 Million | ▲ +446.8% |
| 2009 | 0.17x | CN¥125.31 Million | CN¥21.91 Million | — |